PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

References were also made to the other PPS compositions not...

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    References were also made to the other PPS compositions not meeting the threshold required to be considered as a generic, and at best, may only be considered as a biosimilar, if they are proven to operate in the exact same way as bene's PPS. The invitro studies shown in this article demonstrate the exact opposite.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.